Latest Breaking News On - Gallipoli medical research foundation in queensland - Page 1 : comparemela.com

VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has commenced dosing of patients for its Phase II clinical study in Non-Alcoholic Fatty Liver Disease.

New south walesInvictus ops pty ltdHealth technology limitedHealth technologyGallipoli medical research foundation in queenslandTechnology limitedNon alcoholic fatty liver diseaseNon alcoholic steatohepatitisGallipoli medical research foundationJohn hunter hospitalNew southDavid kingstonChief scientific officerDelayed onset muscle sorenessPrint thisPage viewed